Medicine guide

POMBILITI

As listed in the register: POMBILITI 105 mg, poudre pour solution à diluer pour perfusion

105 mg · poudre pour solution à diluer pour perfusion

  • Prescription only
Active substance
Cipaglucosidase Alfa
Made by
AMICUS THERAPEUTICS EUROPE (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byAMICUS THERAPEUTICS EUROPE (IRLANDE)
Active substanceCipaglucosidase Alfa
Strength105 mg
Formpoudre pour solution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)prescription hospitalière · liste I · les premières administrations doivent être effectuées en milieu hospitalier
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/22/1714
Name in the registerPOMBILITI 105 mg, poudre pour solution à diluer pour perfusion
Packs1 flacon en verre de 20 mL
CIS64427538
CIP133400930272619

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).